BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23299033)

  • 1. What should the blood pressure goal be in patients with hypertension who are at high risk for cardiovascular disease?
    Aronow WS
    Hosp Pract (1995); 2012 Oct; 40(4):28-32. PubMed ID: 23299033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Blood Pressure Goals in Patients With Hypertension at High Risk for Cardiovascular Events.
    Aronow WS
    Am J Ther; 2016; 23(1):e218-23. PubMed ID: 23591024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Borden WB; Maddox TM; Tang F; Rumsfeld JS; Oetgen WJ; Mullen JB; Spinler SA; Peterson ED; Masoudi FA
    J Am Coll Cardiol; 2014 Dec; 64(21):2196-203. PubMed ID: 25447261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.
    Kikuya M; Hansen TW; Thijs L; Björklund-Bodegård K; Kuznetsova T; Ohkubo T; Richart T; Torp-Pedersen C; Lind L; Ibsen H; Imai Y; Staessen JA;
    Circulation; 2007 Apr; 115(16):2145-52. PubMed ID: 17420350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events.
    Chrysant SG; Chrysant GS
    Am J Cardiol; 2010 Sep; 106(6):825-9. PubMed ID: 20816123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
    Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
    Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial.
    Zoungas S; Lui M; Kerr PG; Teede HJ; McNeil JJ; McGrath BP; Polkinghorne KR
    Intern Med J; 2011 Dec; 41(12):825-32. PubMed ID: 20298505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004.
    Wong ND; Lopez VA; L'Italien G; Chen R; Kline SE; Franklin SS
    Arch Intern Med; 2007 Dec; 167(22):2431-6. PubMed ID: 18071164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.
    He J; Whelton PK
    J Hypertens Suppl; 1999 Jun; 17(2):S7-13. PubMed ID: 10465061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study.
    Mishra RK; Kizer JR; Palmieri V; Roman MJ; Galloway JM; Fabsitz RR; Lee ET; Best LG; Devereux RB
    Echocardiography; 2007 Apr; 24(4):340-7. PubMed ID: 17381641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current approaches to the treatment of hypertension in older persons.
    Aronow WS
    Postgrad Med; 2012 Jan; 124(1):50-9. PubMed ID: 22314114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
    Sierra C; Coca A
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1055-62. PubMed ID: 18793108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When is blood pressure lowering needed?].
    Tikkanen I; Tikkanen T
    Duodecim; 1999; 115(8):945-9. PubMed ID: 11859528
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease.
    Kshirsagar AV; Carpenter M; Bang H; Wyatt SB; Colindres RE
    Am J Med; 2006 Feb; 119(2):133-41. PubMed ID: 16443415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.